{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:59:35Z","timestamp":1772643575486,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.retram.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T12:21:38Z","timestamp":1533990098000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL\/6 mice deficient in both apolipoprotein E and Fas ligand"],"prefix":"10.1016","volume":"66","author":[{"given":"Linyu","family":"Geng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songtao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2018.02.002_bib0190","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(13)60889-2","article-title":"Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment","volume":"382","author":"Murphy","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2018.02.002_bib0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2015.08.007","article-title":"Systemic lupus erythematosus and atherosclerosis: review of the literature","volume":"15","author":"Frieri","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.retram.2018.02.002_bib0200","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1517\/14740338.2015.1073259","article-title":"Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review","volume":"14","author":"Benvenuti","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.retram.2018.02.002_bib0205","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.22343","article-title":"Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case\u2013control study","volume":"55","author":"Bessant","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2018.02.002_bib0210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/stem.745","article-title":"Concise review: circulating endothelial progenitor cells for vascular medicine","volume":"29","author":"Asahara","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2018.02.002_bib0215","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000136807.78534.50","article-title":"Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women","volume":"110","author":"El-Magadmi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2018.02.002_bib0220","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/ard.2006.065631","article-title":"Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus","volume":"66","author":"Westerweel","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.retram.2018.02.002_bib0225","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.34504","article-title":"Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis","volume":"64","author":"Thacker","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2018.02.002_bib0230","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/art.23035","article-title":"Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2018.02.002_bib0235","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1001782","article-title":"The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"Thacker","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.retram.2018.02.002_bib0240","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1172\/JCI63835","article-title":"TLRs and IFNs: critical pieces of the autoimmunity puzzle","volume":"122","author":"Theofilopoulos","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2018.02.002_bib0245","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.intimp.2016.10.012","article-title":"The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus","volume":"40","author":"Luo","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.retram.2018.02.002_bib0250","first-page":"246","article-title":"Type I interferon signature in systemic lupus erythematosus","volume":"16","author":"Bezalel","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.retram.2018.02.002_bib0255","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.retram.2018.02.002_bib0260","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/art.30165","article-title":"Interferon-alpha priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-alpha and atherosclerosis in lupus","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2018.02.002_bib0265","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20031557","article-title":"Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease","volume":"199","author":"Aprahamian","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.retram.2018.02.002_bib0270","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1194\/jlr.M600512-JLR200","article-title":"ApoE\u2212\/\u2212Fas\u2212\/\u2212 C57BL\/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia","volume":"48","author":"Feng","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.retram.2018.02.002_bib0275","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12026-012-8270-1","article-title":"TLR7 and TLR9 in SLE: when sensing self goes wrong","volume":"53","author":"Celhar","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.retram.2018.02.002_bib0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.10.001","article-title":"Emerging roles of TLR7 and TLR9 in murine SLE","volume":"33","author":"Santiago-Raber","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.retram.2018.02.002_bib0285","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2018.02.002_bib0290","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0961203309353773","article-title":"Lupus-prone New Zealand Black\/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells","volume":"19","author":"Thacker","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.retram.2018.02.002_bib0295","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/art.22706","article-title":"The role of vascular cell adhesion molecule 1\/very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium","volume":"56","author":"Silverman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2018.02.002_bib0300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nm0603-702","article-title":"Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration","volume":"9","author":"Rafii","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.retram.2018.02.002_bib0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/ten.tec.2012.0312","article-title":"Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix","volume":"19","author":"Andukuri","year":"2013","journal-title":"Tissue Eng Part C Methods"},{"key":"10.1016\/j.retram.2018.02.002_bib0310","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2008.01.002","article-title":"Accelerated atherosclerosis in ApoE deficient lupus mouse models","volume":"127","author":"Ma","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.retram.2018.02.002_bib0315","doi-asserted-by":"crossref","first-page":"e61042","DOI":"10.1371\/journal.pone.0061042","article-title":"The effect of mycophenolate mofetil on disease development in the gld.apoE (\u2212\/\u2212) mouse model of accelerated atherosclerosis and systemic lupus erythematosus","volume":"8","author":"Richez","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.retram.2018.02.002_bib0320","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.RES.0000266449.37396.1f","article-title":"Recipes for creating animal models of diabetic cardiovascular disease","volume":"100","author":"Hsueh","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2018.02.002_bib0325","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1073\/pnas.0602311103","article-title":"Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus","volume":"103","author":"Stanic","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.retram.2018.02.002_bib0330","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.173.3.2134","article-title":"Type I IFN protects against murine lupus","volume":"173","author":"Hron","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.retram.2018.02.002_bib0335","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2741\/4172","article-title":"Endothelial progenitor cells and atherosclerosis","volume":"18","author":"Ruan","year":"2013","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.retram.2018.02.002_bib0340","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170428110311","article-title":"Endothelial progenitor cells as mediators of the crosstalk between vascular repair and immunity: lessons from systemic autoimmune diseases","author":"Rodriguez-Carrio","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.retram.2018.02.002_bib0345","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2007.12.039","article-title":"Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau","volume":"197","author":"Fadini","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.retram.2018.02.002_bib0350","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","article-title":"Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice","volume":"101","author":"Koga","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2018.02.002_bib0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08916930903510963","article-title":"Interferon-alpha as angiogenesis inhibitor: learning from tumor models","volume":"43","author":"Indraccolo","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.retram.2018.02.002_bib0360","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2011-06-359745","article-title":"Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis","volume":"118","author":"Zheng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.retram.2018.02.002_bib0365","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.105.534107","volume":"112","author":"Leppanen","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2018.02.002_bib0370","first-page":"15","article-title":"Non-specific immunotherapy inhibits angiogenesis \u2013 results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy","volume":"66","author":"Prosvicova","year":"2017","journal-title":"Epidemiol Mikrobiol Imunol"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318618300138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318618300138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T20:26:47Z","timestamp":1538166407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318618300138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2452318618300138"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2018.02.002","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL\/6 mice deficient in both apolipoprotein E and Fas ligand","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}